NGID: Next generation immunodermatology (penvoerder Universiteit Leiden)
In the Netherlands over 2.5 million patients suffer from chronic inflammatory skin diseases. Although not life-threatening, the personal impact and socio-economic costs of these chronic conditions are very high. The biggest problem is that many treatments are not suited for every patient and often do not work.
NGID will tackle this problem and will develop the right care for the right patient at the right time. Within this 6-year project six inflammatory skin diseases will be investigated in ultra-high detail. For this approach, a unique, international consortium consisting of scientific institutes, universities, high-tech companies, hospitals, patient associations and (bio)pharmaceutical industry has been setup. Dermatologists from all Dutch University Medical Centers will be connected to biologists, bio-informaticians, statisticians, behavioural scientists, communication researchers and of course to the patient. By means of a new data analysis and integration approach, NGID will make patient-specific fingerprints that will guide the best care for the individual patient in the future.
Projectinformatie
| Type project | Large NWA ORC |
| Looptijd | 2022-2028 |
| Status | Lopend |
|
Onderzoeksgroep(en) |
Metabolomics |
| Projectleiding | Robert Rissman (Universiteit Leiden) |
| Partner(s) | Almirall (NL/ Spanje), Amsterdam Universitair Medische Centra, BIOMAP consortium, EU IMI2, CELLnTEC (Zwitserland), Centre for Human Drug Research, Clinical Microbiomics (Denemarken), Erasmus MC, FibroTx (Estland), Hogeschool Arnhem Nijmegen - University of Applied Sciences, Hogeschool Leiden, Huid Nederland, Janssen-Cilag B.V., Leids Universitair Medisch Centrum, Maastricht University, Maastricht University Medical Center, Maruho (Japan), Nederlandse Vereniging voor Dermatologie en Venereologie, Nederlandse Vereniging voor Experimentele Dermatologie, Perimed AB (Zweden), Proefdiervrij, Psoriasispatiënten Nederland, Radboud Universitair Medisch Centrum, River Diagnostics, Sanquin, Scibase (Zweden), Skin Research Institute of Singapore, Innovative Medicines Initiative, Stichting Huidlymfoom, Technische Universiteit Delft, Universitair Medisch Centrum Groningen, Universitair Medisch Centrum Utrecht, Universiteit van Amsterdam, Universiteit Leiden, Vereniging voor Mensen met Constitutioneel Eczeem |